TY - JOUR T1 - On mobility trends analysis of COVID-19 dissemination in Mexico City JF - medRxiv DO - 10.1101/2021.01.24.21250406 SP - 2021.01.24.21250406 AU - Kernel Prieto AU - M. Victoria Chávez-Hernández AU - Jhoana P. RomeroLeiton Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/25/2021.01.24.21250406.abstract N2 - This work presents a forecast of the spread of the new coronavirus in Mexico City based on a mathematical model with metapopulation structure by using Bayesian Statistics inspired in a data-driven approach. The mobility of humans on a daily basis in Mexico City is mathematically represented by a origin-destination matrix using the open mobility data from Google and a Transportation Mexican Survey. This matrix, is incorporated in a compartmental model. We calibrate the model against borough-level incidence data collected between February 27, 2020 and October 27, 2020 using Bayesian inference to estimate critical epidemiological characteristics associated with the coronavirus spread. Since working with metapopulation models lead to rather high computational time consume, we do a clustering analysis based on mobility trends in order to work on these clusters of borough separately instead of taken all the boroughs together at once. This clustering analysis could be implemented in smaller or lager scale in different part of the world. In addition, this clustering analysis is divided in the phases that the government of Mexico City has set up to restrict the individuals movement in the city. Also, we calculate the reproductive number in Mexico City using the next generation operator method and the inferred model parameters. The analysis of mobility trends can be helpful in public health decisions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We have not used any clinical dataAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used was obtainted in the following websites: https://datos.cdmx.gob.mx/explore/dataset/afluencia-preliminar-en-transporte-publico/table/ https://coronavirus.gob.mx/datos/ https://www.google.com/covid19/mobility/ https://www.inegi.org.mx/programas/eod/2017/ https://www.inegi.org.mx/temas/estructura/default.html#Publicaciones/ https://datos.cdmx.gob.mx/explore/dataset/afluencia-preliminar-en-transporte-publico/table/ https://coronavirus.gob.mx/datos/ https://www.google.com/covid19/mobility/ https://www.inegi.org.mx/programas/eod/2017/ https://www.inegi.org.mx/temas/estructura/default.html#Publicaciones/ ER -